APID Academic Profile Identity
Join · Sign in
Ruby Sengar

Ruby Sengar

Research Director · Bioinformatics
Author
APID
4883
ORCID
0000-0003-2297-9523
Location
B1-301, Sec- 20 Govardhan enclave, Vrindavan Yojna Raebareli Road Lucknow -226301, UTTAR PRADESH, India
Expertise
Cell culture, biotech and bioinfo
Areas of interest
Bioinformatics
Member since
November 2023

Biography

Dr. Ruby singh Sengar, Research director from Gevanam Genomics Pvt. Ltd. Lucknow.
Her PhD research was based on aquaculture and fish viral disease from CIFE , Mumbai and was awarded doctorate degree from Amity University, Lucknow in the year 2020. She found Camphene as an antiviral drug against fish viral disease (viral nervous necrosis ) which damages the retina and brain of fish thus causing major mortality of Barramundi fish which has higher market value and it is a major business of export and import and diminishing the fish was negatively impacting the aquaculture thus agriculture and ecosystem. She did review study even on coronavirus impacting fish industry and she did research in the field of bioinformatics approaches to target fish protein and virtual, screening of antiviral agents against fish betanodavirus, impacting fish industry.

She worked as a scientist in Amor herbal products for 2 years in Lucknow.
She worked as a medical researcher and content writer.
She is recently awarded with ‘Best paper presentation award 2021’ at international conference on agricultural, biological and life sciences at vidya kutir foundation, new Delhi.

She has 6 publication and one book as an editor for the field of aquaculture.
She has gained experience as a reviewer and editor in scientific research paper.

Sign in to see editorial board appointments, follow, and connect.

Publications

  1. Corona Virus Impact on Aquatic World: A Short Review
  2. ISSN (Print): 2211-3525 ISSN (Online): 2211-3533 Research Article In Vitro Validation of Camphene as a Potential Antiviral Agent Against Betanodavirus Causing Viral Nervous Necrosis in Barramundi
  3. In Vitro Validation of Camphene as a Potential Antiviral Agent Against Betanodavirus Causing Viral Nervous Necrosis in Barramundi
  4. In vitro validation of camphene as an antiviral against betanodavirus causing VNN
  5. Screening of camphene as a potential inhibitor targeting SARS- CoV-2 various structural and functional mutants: Through reverse docking approach Mahendra Kumar Savita1,2 ID , Neha Bora3 ID , Ruby Singh4* ID , Prachi Srivastava2* ID
  6. Screening of camphene as a potential inhibitor targeting SARSCoV-2 various structural and functional mutants: Through reverse docking approach
  7. Screening of camphene as a potential inhibitor targeting SARSCoV-2 various structural and functional mutants: Through reverse docking approach